Literature DB >> 11358009

Autoimmune disease-associated lymphadenopathy with histological appearance of T-zone dysplasia with hyperplastic follicles. A clinicopathological analysis of nine cases.

M Kojima1, S Nakamura, T Oyama, T Motoori, H Itoh, K Yoshida, T Suchi, N Masawa.   

Abstract

Autoimmune disease-associated lymphadenopathy shows marked histopathological and clinical diversity. We describe the clinicopathological and immunohistochemical findings of nine cases of autoimmune disease-associated lymphadenopathy, which posed a serious differential diagnostic problem regarding T-zone dysplasia with hyperplastic follicles. There were two males and seven females aged 25 to 65 years (median 37 years). The patients had multicentric lymphadenopathy in association with clinical and laboratory findings suggestive of an "autoimmune disease". Four patients were diagnosed to have systemic lupus erythematosus (SLE), and the remaining five patients had antiphospholipid antibody syndrome and Sjogren's syndrome (SS), rheumatoid arthritis (RA), chronic thyroiditis, RA and SS, and SLE and SS, respectively. None of the nine patients developed malignant lymphomas during the follow-up periods from 44 to 225 months (median 103 months). The lesions were characterized by paracortical hyperplasia with prominent vascular proliferation and many lymphoid follicles with germinal centers. The paracortical area usually contained numerous small T-lymphocytes without cytological atypia, accompanied by a variable number of plasma cells, B-immunoblasts, and histiocytes. Polymerase chain reaction analysis demonstrated no clonal rearrangement of the T-cell receptor chain gene in four cases examined, although immunoglobulin heavy chain rearrangement was detected in only one case. These findings suggest that autoimmune disease-associated lymphadenopathy, especially SLE, shares the histological features with T-zone dysplasia with hyperplastic follicles. The nine cases presented here should be differentiated from T-zone lymphoma with follicles and angioimmunoblastic lymphoma with hyperplastic germinal centers. To avoid overdiagnosis and overtreatment, we emphasize the need to turn attention to these clinical and laboratory findings as well as to the morphological features.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358009     DOI: 10.1078/0344-0338-00041

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjögren's syndrome".

Authors:  Vito Franco; Emilio Iannitto; Claudio Tripodo; Ada Maria Florena
Journal:  Clin Rheumatol       Date:  2005-04       Impact factor: 2.980

2.  The presentation of lymph nodes in Hashimoto's thyroiditis on ultrasound.

Authors:  Mark R Jones; Hossam Mohamed; Jennifer Catlin; Daniel April; Zaid Al-Qurayshi; Emad Kandil
Journal:  Gland Surg       Date:  2015-08

Review 3.  A case report of systemic lupus erythematosus combined with Castleman's disease and literature review.

Authors:  Jing-Yan Xia; Xi-Yuan Chen; Feng Xu; Yan Yang; Hui-Ying Wang; Jing Xue
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

Review 4.  Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases.

Authors:  E M Lopez-Tomassetti Fernandez; H Diaz Luis; A Martin Malagon; I Arteaga Gonzalez; A Carrillo Pallares
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 5.  Lymph node vascular-stromal growth and function as a potential target for controlling immunity.

Authors:  Fairouz Benahmed; Scott Ely; Theresa T Lu
Journal:  Clin Immunol       Date:  2012-05-11       Impact factor: 3.969

Review 6.  [Lymphadenopathy: demarcation to malignant lymphomas].

Authors:  A C Feller
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

7.  Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies.

Authors:  Susan Chyou; Sha Tian; Eric H Ekland; Theresa T Lu
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.